Enyan Yu

989 total citations · 1 hit paper
21 papers, 623 citations indexed

About

Enyan Yu is a scholar working on Psychiatry and Mental health, Clinical Psychology and Physiology. According to data from OpenAlex, Enyan Yu has authored 21 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 6 papers in Clinical Psychology and 5 papers in Physiology. Recurrent topics in Enyan Yu's work include Alzheimer's disease research and treatments (5 papers), Dementia and Cognitive Impairment Research (4 papers) and Obsessive-Compulsive Spectrum Disorders (2 papers). Enyan Yu is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Dementia and Cognitive Impairment Research (4 papers) and Obsessive-Compulsive Spectrum Disorders (2 papers). Enyan Yu collaborates with scholars based in China, Austria and United States. Enyan Yu's co-authors include Serge Gauthier, Huali Wang, Xin Yu, Paola Barbarino, Yanqing Tang, José Luís Molinuevo, Hengge Xie, Wendy Weidner, Yongan Sun and Tao Li and has published in prestigious journals such as The Lancet, PLoS ONE and Neurology.

In The Last Decade

Enyan Yu

19 papers receiving 602 citations

Hit Papers

Dementia care during COVID-19 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enyan Yu China 9 233 189 169 145 69 21 623
Hengge Xie China 9 221 0.9× 222 1.2× 185 1.1× 144 1.0× 87 1.3× 29 687
Geraint Price United Kingdom 10 212 0.9× 84 0.4× 92 0.5× 48 0.3× 57 0.8× 18 619
Freek Gillissen Netherlands 14 72 0.3× 327 1.7× 170 1.0× 75 0.5× 167 2.4× 28 732
Sylvie Pariel France 10 83 0.4× 177 0.9× 135 0.8× 34 0.2× 130 1.9× 23 559
Min Jhon South Korea 15 261 1.1× 121 0.6× 54 0.3× 44 0.3× 42 0.6× 60 701
Hema Madhuri Mekala United States 9 240 1.0× 60 0.3× 92 0.5× 101 0.7× 31 0.4× 19 572
Jinfeng Miao China 14 278 1.2× 52 0.3× 176 1.0× 98 0.7× 61 0.9× 45 851
Colin M. Smith United States 17 314 1.3× 105 0.6× 87 0.5× 146 1.0× 20 0.3× 70 955
Eli Iacob United States 15 81 0.3× 97 0.5× 137 0.8× 33 0.2× 33 0.5× 82 567
Khaled Suleiman Jordan 9 156 0.7× 49 0.3× 136 0.8× 26 0.2× 83 1.2× 34 658

Countries citing papers authored by Enyan Yu

Since Specialization
Citations

This map shows the geographic impact of Enyan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enyan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enyan Yu more than expected).

Fields of papers citing papers by Enyan Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enyan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enyan Yu. The network helps show where Enyan Yu may publish in the future.

Co-authorship network of co-authors of Enyan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Enyan Yu. A scholar is included among the top collaborators of Enyan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enyan Yu. Enyan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brodskiy, Pavel, Klaus Gottlieb, Mohammad Haft‐Javaherian, et al.. (2025). DOP078 Machine learning assessment of endoscopic severity in Ulcerative Colitis trials: Model evaluation against the 2 + 1 reference standard. Journal of Crohn s and Colitis. 19(Supplement_1). i229–i230.
2.
Brodskiy, Pavel, Klaus Gottlieb, Mohammad Haft‐Javaherian, et al.. (2025). P0307 Application of a machine learning model in the 2 + 1 central reading paradigm to assess endoscopic severity in ulcerative colitis trials. Journal of Crohn s and Colitis. 19(Supplement_1). i762–i763.
3.
Xu, Tianhong, et al.. (2025). Advances in the assessment and study of suicide in late-life depression. Frontiers in Psychiatry. 16. 1610730–1610730. 1 indexed citations
4.
Zhang, Wenxuan, et al.. (2025). Effectiveness and Safety of Memantine Add-on Treatment for Refractory Obsessive-Compulsive Disorder: A Meta-Analysis. Journal of College of Physicians And Surgeons Pakistan. 35(4). 494–502. 1 indexed citations
5.
Zhang, Wenxuan, et al.. (2024). Systematic Review and Meta-Analysis: Pharmacological and Nonpharmacological Interventions for Disruptive Mood Dysregulation Disorder. Journal of Child and Adolescent Psychopharmacology. 34(5). 217–225. 2 indexed citations
6.
7.
Qiu, Shuxian, Mei Zhao, Haifeng Zhang, et al.. (2024). Heterogeneity in the level of dementia literacy among community doctors in China: A latent profile analysis. Journal of Global Health. 14. 4161–4161. 3 indexed citations
8.
Jin, Piaopiao, et al.. (2023). A review of current evidence for mild behavioral impairment as an early potential novel marker of Alzheimer’s disease. Frontiers in Psychiatry. 14. 1099333–1099333. 22 indexed citations
9.
Huang, Yan, Jiaxi Xu, Xuehao Zhang, Yuhe Liu, & Enyan Yu. (2023). Research progress on vestibular dysfunction and visual–spatial cognition in patients with Alzheimer’s disease. Frontiers in Aging Neuroscience. 15. 1153918–1153918. 14 indexed citations
11.
Bai, Lu & Enyan Yu. (2021). A narrative review of risk factors and interventions for cancer- related cognitive impairment. Annals of Translational Medicine. 9(1). 72–72. 33 indexed citations
12.
Su, Heng, et al.. (2021). Low-dose clozapine-related seizure: A case report and literature review. World Journal of Clinical Cases. 9(20). 5611–5620. 1 indexed citations
14.
Yu, Enyan, Zhengluan Liao, Weixing Fan, et al.. (2021). The Economic Burden of Alzheimer’s Disease in Zhejiang Province. Journal of Alzheimer s Disease. 80(2). 539–553. 8 indexed citations
15.
Wang, Huali, Tao Li, Serge Gauthier, et al.. (2020). Coronavirus epidemic and geriatric mental healthcare in China: how a coordinated response by professional organizations helped older adults during an unprecedented crisis. International Psychogeriatrics. 32(10). 1117–1120. 27 indexed citations
16.
Wang, Huali, Tao Li, Paola Barbarino, et al.. (2020). Dementia care during COVID-19. The Lancet. 395(10231). 1190–1191. 381 indexed citations breakdown →
17.
Xu, Songxiao, Xiangdong Cheng, Zhiwen Pan, et al.. (2020). Cancer patient management strategy in a Cancer Center of Zhejiang, China during the COVID-19 pandemic. BMC Cancer. 20(1). 1194–1194. 6 indexed citations
18.
Li, Xiaoyi, et al.. (2013). The Combined Treatment of Venlafaxine and Quetiapine for Treatment-Resistant Depression: A Clinical Study. Journal of Neuropsychiatry. 25(2). 157–160. 6 indexed citations
19.
Feng, Bin, et al.. (2005). [Clinical study on treatment of obsessive compulsive neurosis by acupoint stimulating control].. PubMed. 25(9). 801–3. 2 indexed citations
20.
Katzman, Robert, Ning Yan Gu, Shuang Jiang, et al.. (1997). Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia. Neurology. 49(3). 779–785. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026